Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
PLSE
#1951
Pulse Biosciences, Inc Common Stock (DE)
18.730
0
-0.58%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.58%
Changement Mensuel
+30.89%
Evolution sur 6 mois
+3.20%
Changement Annuel
+3.20%
Clôture Précédente
18.840
0
Open
18.730
0
Bid
Ask
Low
18.730
0
High
18.730
0
Volume
54
Marchés
Actions des Marchés US
Soins de Santé
PLSE
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.09 M
29.8 M
37.59 M
55.23 M
67.27 M
67.99 M
—
Valuation ratios
Enterprise value
609.97 M
412.76 M
42.24 M
564.22 M
1.05 B
852.76 M
3.83 B
Price to earnings ratio
—
—
-1.6
-12.54
-18.97
12.71
-32.93
Price to sales ratio
—
—
133.32
—
—
2 643.82
—
Price to cash flow ratio
—
—
-1.99
-16.02
-27.98
17.1
-53.09
Price to book ratio
—
—
-41.51
11.93
8.85
11.47
19.35
Enterprise value to EBITDA ratio
-12.35
-12.19
-1.16
-36.96
—
-11.14
—
Profitability ratios
Return on assets %
1.21
1.17
0.75
0.71
0.4
-0.77
0.28
Return on equity %
2.18
1.78
26.03
0.95
0.47
-0.9
0.32
Return on invested capital %
761.9
1 240.68
1 276.4
1 075.01
1 538.65
-2 275.12
—
Gross margin %
—
-38.79
-1 606.29
—
—
-54
—
Operating margin %
—
4 443.86
8 293.86
—
—
-21.98 K
—
EBITDA margin %
—
-2 388.86
-5 190.43
—
—
-21.87 K
—
Net margin %
—
4 492.24
8 357.86
—
—
-20.79 K
—
Liquidity ratios
Quick ratio
—
3.62
10.39
—
—
10.51
48.14
Current ratio
2.95
4.3
10.39
6.76
11.88
10.53
48.17
Inventory turnover
—
0.1
2.91
—
—
—
—
Asset turnover
0
0.03
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.01
0
0
—
—
—
Long term debt to total equity ratio
—
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.39
0.69
0.62
-0.8
0.37
EBIT per share
—
—
-1.11
-0.34
—
-1.15
—
EBITDA per share
—
—
-1.07
-0.32
—
-1.14
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.8
0.92
2.02
1.2
5.97
Net current asset value per share
—
—
1.83
0.94
2.05
1.24
6.09
Tangible book value per share
—
—
0.14
0.99
2.03
1.27
6.15
Working capital per share
—
—
1.66
0.8
1.87
1.12
5.58
Book value per share
—
—
0.07
0.92
1.97
1.2
5.89
Nouvelles
Le directeur commercial de Pulse Biosciences démissionne avec effet immédiat
Pulse Biosciences chief commercial officer resigns effective immediately
Le CCO de Pulse Biosciences Danahy vend pour 118.000$ d’actions PLSE
Pulse Biosciences CCO Danahy sells $118k in PLSE stock
Oppenheimer relève l’objectif de cours de Pulse Biosciences à 30$
Oppenheimer raises Pulse Biosciences stock price target to $30
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
Le BPA de Pulse Biosciences a dépassé les attentes de 0,07$, le CA en dessous des prévisions
Les résultats de Pulse Biosciences sous surveillance après l’envolée des données cliniques
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Pulse Biosciences CCO Danahy sells $1.41 million in stock